Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DMAU56
|
|||
| Drug Name |
mRNA-5671
|
|||
| Drug Type |
Vaccine
|
|||
| Indication | Non-small-cell lung cancer [ICD-11: 2C25.Y; ICD-9: 162] | Phase 1 | [1] | |
| Company |
Moderna Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03948763) A Study of mRNA-5671/V941 as Monotherapy and in Combination With Pembrolizumab (V941-001). U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.